DUBLIN--(BUSINESS WIRE)--The "Pneumonia - Treatment Report" report has been added to Research and Markets' offering.
Informed by real-world data from an Electronic Health Record (EHR) database of clinical and administrative records spanning 273 million encounters for 60 million patients in 600+ hospitals across the US, this report estimates 30% of all hospital discharges involve treatment of infectious organisms.
Pneumonia is responsible for an estimated 12% of all hospital stays. At an average cost of $15,500 per occurrence, we estimate that hospitalizations for severe infections account for around $212 billion in annual spending or 7% of total healthcare expenditure. In this report, we conduct an in-depth analysis of pneumonia patient characteristics, medication management, costs, and laboratory testing.
Gram-negative bacteria are the likely causative agents of most pneumonia infections and physicians treat most of these patients with levofloxacin, ceftriaxone, and azithromycin. This report provides quantitative, objective data focused on the treatment of pneumonia requiring hospitalization captured by hospitals contributing to Cerner Health Facts. This data provides real-world patient encounters and reflects real physician decisions and encounter characteristics (e.g. patient response to therapy and outcomes) in key areas, such as antimicrobial stewardship.
Key Topics Covered:
1. Patient Flow
2. Executive Summary
3. Incidence and Impact of Disease
- Incidence
- Length of Stay
- Total Cost
4. Patient Demographics
- Age
- Insurance type
- Gender
- Region
- Mortality
- Comorbid Conditions
5. Patient Flow through the Hospital
- Admission Site
- Lab Testing
- Lab TAT
- Results
- Etiology
- Empiric Therapy
- Change in treatment
6. Drug Share for Key Therapeutics
- Most Common
- LOS
- APACHE Score
- Treatment Duration
-
Product Dashboards
- Market Share
- Demographics
- Hospitalization
7. Outcomes of Treatment
- Antibiotic Usage
- Mortality
- Cost per Patient
8. Database Overview
9. Methodology
For more information about this report visit https://www.researchandmarkets.com/research/pwsxjc/pneumonia
